GHRL and neoplasm: While the specifics of this interaction have been intensely investigated and revolve mainly around the enzymatic acylation of ghrelin through ghrelin-o-acyltransferase [58], recent evidence suggests new intricacies in both circulating and local tissue interactions, with novel splice variants of ghrelin identified and investigated as potential promotors of tumor progression and invasion [59,60,61].